[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 63, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 62, "title": "President & COO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 61, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 69, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.61, "open": 7.6, "dayLow": 7.43, "dayHigh": 7.63, "regularMarketPreviousClose": 7.61, "regularMarketOpen": 7.6, "regularMarketDayLow": 7.43, "regularMarketDayHigh": 7.63, "payoutRatio": 0.0, "beta": 0.94, "forwardPE": 23.656597, "volume": 1285278, "regularMarketVolume": 1285278, "averageVolume": 2464759, "averageVolume10days": 1767050, "averageDailyVolume10Day": 1767050, "bid": 5.46, "ask": 9.62, "bidSize": 2, "askSize": 2, "marketCap": 1234476672, "fiftyTwoWeekLow": 3.37, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 27.98, "allTimeLow": 0.97, "priceToSalesTrailing12Months": 4.6385007, "fiftyDayAverage": 7.2354, "twoHundredDayAverage": 6.5102, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1400532736, "profitMargins": -0.058769997, "floatShares": 158723175, "sharesOutstanding": 165924289, "sharesShort": 16522754, "sharesShortPriorMonth": 15974039, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0996, "heldPercentInsiders": 0.03862, "heldPercentInstitutions": 0.59686, "shortRatio": 7.51, "shortPercentOfFloat": 0.1035, "impliedSharesOutstanding": 165924289, "bookValue": -0.005, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -15640000, "trailingEps": -0.1, "forwardEps": 0.3145, "enterpriseToRevenue": 5.262, "enterpriseToEbitda": 49.955, "52WeekChange": 1.1440923, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 7.44, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.14286, "targetMedianPrice": 10.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 91598000, "totalCashPerShare": 0.552, "ebitda": 28036000, "totalDebt": 257654000, "quickRatio": 1.251, "currentRatio": 1.928, "totalRevenue": 266136992, "revenuePerShare": 1.704, "returnOnAssets": 0.02875, "grossProfits": 225036992, "freeCashflow": 28553500, "operatingCashflow": 10558000, "revenueGrowth": 0.371, "grossMargins": 0.84556997, "ebitdaMargins": 0.105340004, "operatingMargins": 0.09049, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Xeris Biopharma Holdings, Inc.", "shortName": "Xeris Biopharma Holdings, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "regularMarketChangePercent": -2.2339, "regularMarketPrice": 7.44, "postMarketChangePercent": 0.13440527, "postMarketPrice": 7.45, "postMarketChange": 0.009999752, "regularMarketChange": -0.17, "regularMarketDayRange": "7.43 - 7.63", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2464759, "fiftyTwoWeekLowChange": 4.07, "fiftyTwoWeekLowChangePercent": 1.2077153, "fiftyTwoWeekRange": "3.37 - 10.08", "fiftyTwoWeekHighChange": -2.6399999, "fiftyTwoWeekHighChangePercent": -0.26190475, "fiftyTwoWeekChangePercent": 114.40923, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.1, "epsForward": 0.3145, "epsCurrentYear": 0.063, "priceEpsCurrentYear": 118.09524, "fiftyDayAverageChange": 0.20459986, "fiftyDayAverageChangePercent": 0.028277615, "twoHundredDayAverageChange": 0.92980003, "twoHundredDayAverageChangePercent": 0.14282204, "priceToBook": -1488.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2026-01-24", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1769209242, "regularMarketTime": 1769202000, "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]